School of Medicine
Showing 111-120 of 160 Results
-
Neha Patel, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Neha Patel is a triple board-certified, fellowship-trained medical oncologist with Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Patel provides expert, personalized care for patients with both common and rare cancers and specializes in treating patients with genitourinary cancer. She is deeply committed to delivering comprehensive, patient-centered oncology services, with an emphasis on helping individuals and their families understand their diagnosis and navigate treatment options with confidence and clarity.
Her research focuses on designing and implementing system-level interventions to advance equitable, high-value cancer care. Dr. Patel is particularly passionate about integrating oncology and palliative (symptom-relieving) care—creating collaborative models that improve patient outcomes, elevate the quality of life, and enhance the overall care experience.
Known for her compassionate and relational approach, Dr. Patel builds strong, trusting partnerships with the patients and families she serves. She prioritizes care that aligns with each individual’s values, preferences, and goals, with the aim of achieving the best possible quality of life and longevity. -
Mark Pegram
Susy Yuan-Huey Hung Professor
Current Research and Scholarly InterestsMolecular mechanisms of targeted therapy resistance in breast and other cancers
-
Harlan Pinto
Associate Professor of Medicine (Oncology), Emeritus
Current Research and Scholarly InterestsClinical Interests: general oncology, head and neck cancer Research Interests: chemoprevention trials and combined modality approaches to head and neck cancer
-
Klaus Porzig
Emeritus Adjunct Clinical Professor, Medicine - Oncology
BioKlaus Porzig is an Emeritus Adjunct Clinical Professor at Stanford. He was active in Stanford’s clinical oncology program from 1979 until 2008. He was an Attending Physician on the Oncology inpatient service (MED III initially and then MED X) annually from 1979 until retirement in 2008. He was active in the breast cancer program during those decades. Dr. Porzig was a founding partner in South Bay Oncology in 1979 which became part of the Stanford Cancer Center in the Southbay after his retirement. He was a member of the council of the California Breast Cancer Research Program from 2006-2010 and served as the Chair of the CBCRP council 2008-2009. From 2013 to 2021, he was a member of the Stanford Medicine Alumni Association Board of Governors and served as chair of the Awards Committee during that time. Klaus has been a docent at Stanford's Jasper Ridge Biological Preserve since 2018.
PROFESSIONAL EDUCATION
B.A., Stanford University, Biology “With Great Distinction” and “Departmental Honors” (1969)
M.D., Stanford University School of Medicine (1973)
POSTGRADUATE TRAINING
Internship: Internal Medicine, University of California, San Francisco (1973-74)
Residency: Internal Medicine, Stanford (1974-75)
Research Fellowship: Laboratory of Cellular and Molecular Biology, National Cancer Institute, NIH (1976-78)
Clinical Fellowship: Medical Oncology, Stanford University (1975-76, 1978-79)
ACADEMIC HONORS AND AWARDS
Phi Beta Kappa (1968)
Alpha Omega Alpha (1972)
Winslow J. Cutting Book Award for research in Pharmacology, Stanford (1973)
Russel V. Lee Clinical Teaching Award for Excellence in Clinical Teaching, Medicine, Stanford (1994,1997,1999, and 2000)
Thomas E. Davis Award for Clinical Teaching, Oncology, Stanford (1995)
Honorary Lifetime Medical Staff, Stanford University Hospital (2013) -
Kavitha Ramchandran
Clinical Professor, Medicine - Oncology
Current Research and Scholarly InterestsMy research focuses on innovative models of care delivey to understand how to integrate primary and specialist palliative care. We also do work in palliative care education and how to scale our education to be impactful and sustainable. We are evaluating online models.
In cancer care I do research on novel therapeutics in thoracic malignancies including immunotherapy, new targeted agents, and new sequencing of approved drugs. -
Julia D. Ransohoff
Instructor, Medicine - Oncology
BioDr. Ransohoff received her B.A. from Harvard College in Human Developmental and Regenerative Biology and completed her medical training at Stanford University, where she received her M.D., completed residency in internal medicine, and fellowship training in hematology and oncology as part of the American Board of Internal Medicine Physician Scientist Training Program.
Dr. Ransohoff is a physician-scientist dedicated to improving breast cancer treatments and outcomes through developing genomic methods to profile how tumors respond to treatment. Her research focuses on molecular approaches to understand the variable clinical responses of breast cancers to treatment at the genomic level by profiling molecular residual disease. Her current work involves exploring mechanisms of chemoresistance and immune evasion and identifying novel therapeutic targets. In related work, she also studies epidemiological risk factors for breast cancer mortality with a focus on the gut microbiome, oncofertility, and racial and ethnic differences in treatment response. Dr. Ransohoff's research has been supported by the ASCO Conquer Cancer Foundation, the Terri Brodeur Breast Cancer Foundation, the Stanford Cancer Institute, ECOG-ACRIN, and the Chan Zuckerberg Initiative.
As an Instructor in the Division of Medical Oncology, Dr. Ransohoff is also a clinically active oncologist, treating patients with breast cancer.
